Bone Biologics Corporatio... (BBLG)
0.83
-0.06 (-6.61%)
At close: Mar 03, 2025, 3:59 PM
0.80
-3.94%
After-hours: Mar 03, 2025, 05:28 PM EST
Bone Biologics Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| PE Ratio | -0.19 | -0.13 | 1.70 | -11.29 | -40.71 | -21.69 | n/a | n/a | n/a | n/a | n/a | n/a | -240.65 | n/a | n/a | n/a | -4.61M |
| PEG Ratio | 0.00 | -0.01 | -0.1 | -2.41 | 0.87 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 0.41 | 0.41 | 0.20 | 2.77 | -5.42 | -6.26 | n/a | n/a | n/a | n/a | n/a | n/a | -36.82 | n/a | n/a | n/a | n/a |
| P/FCF Ratio | -0.35 | -0.12 | -0.33 | -14.8 | -173.98 | -22.85 | n/a | n/a | n/a | n/a | n/a | n/a | -384.82 | -10.83M | -1.35M | -12.63M | -2.53M |
| P/OCF Ratio | -0.35 | -0.12 | -0.33 | -14.8 | -173.98 | -22.85 | n/a | n/a | n/a | n/a | n/a | n/a | -384.82 | -10.83M | -1.35M | -12.63M | -2.53M |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | n/a | n/a | n/a | n/a | -0.86 | -0.95 | -1.05 | -0.98 | -0.87 | -0.99 | -1.97 | -0.74 | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 10.22 | 4.50 | 3.56 | 66.81 | n/a | 0.05 | 0.11 | 0.83 | 0.29 | 0.97 | 0.73 | 0.02 | 0.00 | n/a | n/a | n/a | n/a |
| Current Ratio | 10.22 | 4.50 | 3.33 | 66.81 | n/a | 0.05 | 0.11 | 0.83 | 0.29 | 0.97 | 0.98 | 0.02 | 0.00 | n/a | n/a | n/a | n/a |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | -1.37 | -0.83 | -2.51 | -2.27 | -0.59 | -5.63 | -6.41 | -2.15 | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -2.1 | -3.08 | 0.12 | -0.24 | 0.13 | 0.29 | 0.52 | 0.84 | 2.44 | 2.44 | 1.20 | 0.19 | 0.15 | n/a | n/a | n/a | n/a |
| Return on Assets (ROA) | -1.9 | -2.39 | 0.08 | -0.24 | n/a | -111.1 | -4.26 | -8.86 | -21.61 | -6.67 | -1.16 | -12.4 | -301.93 | n/a | n/a | n/a | n/a |
| Return on Capital (ROIC) | -1.21 | -3.24 | -0.62 | -0.17 | 0.06 | 4.47 | 0.32 | 15.81 | 7.59 | 184.64 | 56.46 | 0.12 | 0.09 | n/a | n/a | 0.08 | n/a |
| Dividend Yield | 2.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | -0.44 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |